Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 53% ± 27% | |
GABAergic neuron | 9 studies | 43% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 38% ± 16% | |
interneuron | 6 studies | 49% ± 13% | |
granule cell | 4 studies | 65% ± 13% | |
oligodendrocyte | 4 studies | 34% ± 18% | |
neuron | 3 studies | 28% ± 10% | |
endothelial cell | 3 studies | 58% ± 6% | |
GABAergic interneuron | 3 studies | 37% ± 5% | |
GABAergic amacrine cell | 3 studies | 19% ± 4% | |
amacrine cell | 3 studies | 60% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 40% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1007.38 | 2616 / 2642 | 58% | 2.47 | 407 / 705 |
pancreas | 94% | 263.08 | 307 / 328 | 55% | 3.67 | 98 / 178 |
prostate | 40% | 47.62 | 99 / 245 | 87% | 2.88 | 435 / 502 |
thymus | 27% | 32.22 | 178 / 653 | 74% | 4.70 | 448 / 605 |
breast | 53% | 198.84 | 242 / 459 | 48% | 2.98 | 536 / 1118 |
adrenal gland | 26% | 42.85 | 68 / 258 | 71% | 11.26 | 164 / 230 |
kidney | 47% | 62.53 | 42 / 89 | 49% | 2.03 | 440 / 901 |
ovary | 4% | 5.86 | 7 / 180 | 63% | 2.61 | 271 / 430 |
esophagus | 15% | 18.22 | 221 / 1445 | 41% | 3.02 | 75 / 183 |
lung | 2% | 1.83 | 12 / 578 | 54% | 3.54 | 621 / 1155 |
uterus | 22% | 31.73 | 37 / 170 | 30% | 1.48 | 139 / 459 |
skin | 37% | 48.35 | 673 / 1809 | 5% | 0.15 | 25 / 472 |
intestine | 22% | 26.01 | 211 / 966 | 6% | 0.17 | 30 / 527 |
stomach | 20% | 25.04 | 72 / 359 | 5% | 0.25 | 13 / 286 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.09 | 10 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.40 | 6 / 29 |
bladder | 0% | 0 | 0 / 21 | 15% | 0.71 | 77 / 504 |
liver | 0% | 0 | 0 / 226 | 13% | 0.71 | 51 / 406 |
peripheral blood | 7% | 13.27 | 66 / 929 | 0% | 0 | 0 / 0 |
muscle | 5% | 5.69 | 42 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.82 | 10 / 1335 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.83 | 7 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015888 | Biological process | thiamine transport |
GO_0016020 | Cellular component | membrane |
Gene name | SLC35F3 |
Protein name | Solute carrier family 35 member F3 (Thiamine transporter SLC35F3) |
Synonyms | |
Description | FUNCTION: Mediates thiamine transport. . |
Accessions | Q8IY50 ENST00000366617.3 [Q8IY50-1] ENST00000366618.8 [Q8IY50-2] |